You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
開拓藥業-B(09939.HK)擬先舊後新配售2067.3萬股 淨籌4034萬港元

格隆匯8月1日丨開拓藥業-B(09939.HK)發佈公告,2025年8月1日(交易時段前),公司、童友之博士及賣方(即KT International Investment Limited,由童博士全資擁有)與配售代理(即中銀國際)訂立該協議,據此,(i)賣方同意出售而配售代理同意(作爲賣方的代理)盡最大努力促使買方按每股股份2.08港元的價格購買賣方持有的合共2067.3萬股股份,相當於公司於本公告日期的已發行股本約4.62%;及(ii)賣方有條件同意作爲委託人按認購價(相當於配售價每股股份2.08港元)認購而公司有條件同意發行2067.3萬股新股份(即認購股份)。

進行配售事項及認購事項旨在補充集團的一般業務及增長策略的長期資金。董事認爲,配售事項及認購事項亦將爲公司提供進一步集資的機會,同時擴大公司的股東基礎及資本基礎。經扣除相關費用及開支後,認購事項的所得款項淨額估計約爲4034萬港元。公司擬將認購事項所得款項淨額用於集團的一般營運資金及一般業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account